Skip to main content

Alland Leila

In the past year, 2 open-market sale filings worth $157.0K and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$157.0K
2 filings
Net
−$157.0K
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Alland Leila as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

ABEO Abeona Therapeutics Inc.

Director4 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 29, 2023 (view filing)Sep 272 daysAlland LeilaDirectorSSale−7.25K$3.90−$28.3K−9.2%71.9K after
May 20, 2024 (view filing)May 164 daysAlland LeilaDirectorPPurchase+11.0K$4.71+$51.8K+15.3%82.9K after
Feb 2, 2026 (view filing)Feb 2Same dayAlland LeilaDirectorSSale−18.1K$5.09−$92.0K−9.4%173.6K after
Jul 2, 2026 (view filing)4:30 PM ETJun 302 daysAlland LeilaDirectorSSale−11.0K$5.92−$65.1K−6.3%162.6K after

PMVP PMV Pharmaceuticals, Inc.

Chief Medical Officer5 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 8, 2021 (view filing)Jul 71 dayAlland LeilaChief Medical OfficerSSale−4.00K$32.30−$129.2K−100.0%0 after2 lots
Aug 10, 2021 (view filing)Aug 91 dayAlland LeilaChief Medical OfficerSSale−4.47K$34.04−$152.2K−100.0%0 after3 lots
Sep 8, 2021 (view filing)Sep 71 dayAlland LeilaChief Medical OfficerSSale−3.90K$30.25−$118.0K−100.0%0 after
Sep 10, 2021 (view filing)Sep 91 dayAlland LeilaChief Medical OfficerSSale−100$30.25−$3.02K−100.0%0 after
Sep 18, 2023 (view filing)Sep 153 daysAlland LeilaChief Medical OfficerSSale−6.29K$6.62−$41.6K−12.1%45.9K after